The Significance Of Positive Surgical Margin In Areas Of Capsular Incision In Otherwise Organ Confined Disease At Radical Prostatectomy
Main Category: Prostate / Prostate CancerAlso Included In: Urology / Nephrology
Article Date: 30 Dec 2007 - 1:00 PDT
| Patient / Public: | ![]() |
4 (1 votes) |
| Healthcare Prof: | ![]() |
4.5 (2 votes) |
UroToday.com- There is a lack of consensus regarding the impact of prostatic capsular incision in otherwise organ confined disease. In the October issue of the Journal of Urology, Dr. Chuang and the associates from Korea and the Johns Hopkins University report that capsular incision may result in a higher cancer recurrence rate
Cases of capsular incision were retrospectively identified from pathology reports from the period 1993-2004. These pathology specimens were reviewed. Tumor at an inked margin was considered a positive surgical margin (PSM). Extension of the tumor to the inked margins in the same plane where benign prostatic acni were also present at the inked margin were considered to have a PSM due to capsular incision. The study evaluated only cases with a PSM in an area of capsular incision. Elsewhere in the specimen there was no extra-prostatic extension, seminal vesicle invasion, or lymph node metastasis. The lengths of the capsular incision, total tumor, and benign prostate glands at the ink in an area of capsular incision were measured. The capsular incision Gleason score and overall tumor Gleason score were recorded. These data were compared to other pathological groups in the institution's database; to include focal extraprostatic extension (FEPE) margin negative, FEPE margin positive, extensive EPE margin negative and extensive EPE margin positive.
There were 135 cases of capsular incision during this time period representing 1.3% of the total RPs performed with Gleason score 6-7. Median patient age of the capsular incision group was 58 and 94.8% had only one area of capsular incision. The median length of tumor at the capsular incision site was 2mm. Capsular incision was posterolateral in 61.5%, posterior in 18.5%, anterior in 8.9%, lateral in 8.1%, and apical in 3%. The overall Gleason score at the site on incision was 6 in 73% and 7 in 28%. Of the cohort, 113 men had followup data available and the 5-year actuarial freedom from recurrence was 97% for organ confined surgical margin negative, 90% for FEPE margin negative, 79% for FEPE margin positive, 74% for extensive EPE margin negative, 71% for capsular incision into the tumor, and 59% for extensive EPE margin positive. Patients with capsular incision had a higher risk of progression than men with organ confined margin negative or FEPE margin negative disease. The risk of disease progression with capsular incision, FEPE margin negative, and extensive EPE margin negative were not different.
The researchers report that risk of disease recurrence correlated with tumor length at the capsular incision site. For less than 3mm tumor at the capsular incision site, the 5-year risk of PSA progression was 20%, compared to 55% if there was a 3mm or more tumor.
Chuang AY, Nielsen ME, Hernandez DJ, Walsh PC, Epstein JI
J Urol. 178(4): 1306- 1310, October 2007
Reported by UroToday.com Contributing Editor Christopher P. Evans, M.D
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.
To access the latest urology news releases from UroToday, go to: www.urotoday.com
----------------------------
Copyright © 2007 - UroToday
Reproduced for Medical News Today with permission of UroToday.
----------------------------
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
13 Feb. 2012. <http://www.medicalnewstoday.com/releases/92781.php>
APA
http://www.medicalnewstoday.com/releases/92781.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




